Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
Brok J, Mavinkurve-Groothuis AMC, Drost J, Perotti D, Geller JI, Walz AL, Geoerger B, Pasqualini C, Verschuur A, Polanco A, Jones KP, van den Heuvel-Eibrink M, Graf N, Spreafico F. Brok J, et al. Eur J Cancer. 2021 Feb;144:113-122. doi: 10.1016/j.ejca.2020.11.012. Epub 2020 Dec 18. Eur J Cancer. 2021. PMID: 33341445 Review.
Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Mavinkurve-Groothuis AM, van den Heuvel-Eibrink MM, Tytgat GA, van Tinteren H, Vujanic G, Pritchard-Jones KL, Howell L, Graf N, Bergeron C, Acha T, Catania S, Spreafico F. Mavinkurve-Groothuis AM, et al. Pediatr Blood Cancer. 2015 Apr;62(4):598-602. doi: 10.1002/pbc.25357. Epub 2014 Dec 29. Pediatr Blood Cancer. 2015. PMID: 25546733 Clinical Trial.
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.
Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Pritchard-Jones K, et al. Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Free article. Clinical Trial.
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.
Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC. Hol JA, et al. Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26849. Epub 2017 Oct 27. Pediatr Blood Cancer. 2018. PMID: 29077255 Clinical Trial.
TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ, Hoyer J, Ekici AB, Popp B, Hoogerbrugge N, van Reijmersdal SV, Bhaskaran R, Hadjihannas M, Vasileiou G, Thiel CT, Seven D, Uebe S, Ilencikova D, Waanders E, Mavinkurve-Groothuis AMC, Roeleveld N, de Krijger RR, Wegert J, Graf N, Vokuhl C, Agaimy A, Gessler M, Reis A, Kuiper RP, Jongmans MCJ, Metzler M. Diets IJ, et al. Int J Cancer. 2019 Aug 15;145(4):941-951. doi: 10.1002/ijc.32167. Epub 2019 Feb 14. Int J Cancer. 2019. PMID: 30694527 Free article.
A Role of brachytherapy in bilateral Wilms tumors: A long-term follow-up of three highly selected cases and literature review.
Dávila Fajardo R, Pieters BR, Wilde JCH, Heij HA, Chrzan R, Tytgat G, Mavinkurve-Groothuis AMC, Smets A, Kroon PS, Van Damme A, van de Ven KP, de Krijger RR, Lilien MR, Wijnen MH, van den Heuvel-Eibrink MM, Janssens GO. Dávila Fajardo R, et al. Brachytherapy. 2021 Mar-Apr;20(2):478-484. doi: 10.1016/j.brachy.2020.09.001. Epub 2020 Dec 9. Brachytherapy. 2021. PMID: 33309284 Free article. Review.
Locoregional control using highly conformal flank target volumes and volumetric-modulated arc therapy in pediatric renal tumors: Results from the Dutch national cohort.
Mul J, van Grotel M, Seravalli E, Bosman ME, van Tinteren H, Roy P, Dávila Fajardo R, Tytgat GAM, Mavinkurve-Groothuis AMC, van de Ven CP, Wijnen MHWA, de Krijger RR, Littooij AS, van den Heuvel-Eibrink MM, Janssens GO. Mul J, et al. Radiother Oncol. 2021 Jun;159:249-254. doi: 10.1016/j.radonc.2021.04.005. Epub 2021 Apr 13. Radiother Oncol. 2021. PMID: 33845042 Free article.
Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature.
Groenendijk A, Spreafico F, de Krijger RR, Drost J, Brok J, Perotti D, van Tinteren H, Venkatramani R, Godziński J, Rübe C, Geller JI, Graf N, van den Heuvel-Eibrink MM, Mavinkurve-Groothuis AMC. Groenendijk A, et al. Cancers (Basel). 2021 Jun 23;13(13):3142. doi: 10.3390/cancers13133142. Cancers (Basel). 2021. PMID: 34201787 Free PMC article. Review.
Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approach.
Rutgers JJ, Bánki T, van der Kamp A, Waterlander TJ, Scheijde-Vermeulen MA, van den Heuvel-Eibrink MM, van der Laak JAWM, Fiocco M, Mavinkurve-Groothuis AMC, de Krijger RR. Rutgers JJ, et al. Diagn Pathol. 2021 Aug 21;16(1):77. doi: 10.1186/s13000-021-01136-w. Diagn Pathol. 2021. PMID: 34419100 Free PMC article.
Bilateral Renal Tumors in Children: The First 5 Years' Experience of National Centralization in The Netherlands and a Narrative Review of the Literature.
van Peer SE, Hol JA, van der Steeg AFW, Grotel MV, Tytgat GAM, Mavinkurve-Groothuis AMC, Janssens GOR, Littooij AS, de Krijger RR, Jongmans MCJ, Lilien MR, Drost J, Kuiper RP, van Tinteren H, Wijnen MHWA, van den Heuvel-Eibrink MM. van Peer SE, et al. J Clin Med. 2021 Nov 26;10(23):5558. doi: 10.3390/jcm10235558. J Clin Med. 2021. PMID: 34884260 Free PMC article.
84 results